[1]Mori M, Imaizumi M, Ishiwada N,et al.Pharmacokinetics, efficacy, and safety of caspofungin in Japanese pediatric patients with invasive candidiasis and invasive aspergillosis[J]. J Infect Chemother,2015, 21(6): 421-426.
[2]Muilwijk EW, Schouten JA, van Leeuwen HJ,et al.Pharmacokinetics of caspofungin in ICU patients[J] J Antimicrob Chemother, 2014, 69(12): 3294-3299.
[3]Schlamm HT, Marr KA.Combination therapy for invasive aspergillosis: controversies and conclusions[J]. Current Fungal Infection Reports, 2015, 9(2): 1-5.
[4]Mori M, Imaizumi M, Ishiwada N,et al. Pharmacokinetics, efficacy, and safety of caspofungin in Japanese pediatric patients with invasive candidiasis and invasive aspergillosis[J]. J Infect Chemother, 2015, 21(6): 421-426.
[5] Avolio A, Pensi D, Baietto L, et al.Therapeutic drug monitoring of intracellular anti-infective agents [J]. J Pharm Biomed Anal, 2014, 101: 183-193.
[6]Rochat B, Bolay S, Pascual A, et al.Liquid chromatography-mass spectrometry method for quantification of caspofungin in clinical plasma samples[J]. J Mass Spectrom, 2007, 42(4): 440-449.
[7]Burhenne H, Kielstein JT, Burkhardt O, et al.Quantitative analysis of the antifungal drug anidulafungin by LC-online SPE-MS/MS in human plasma[J]. Biomed Chromatogr, 2012, 26(6): 681-683.
[8]Farowski F, Cornely OA, Vehreschild JJ, et al. Quantitation of azoles and echinocandins in compartments of peripheral blood by liquid chromatographytandem mass spectrometry [J] .Antimicrob Agents Chemother, 2010,54 (5): 1815 -1819.
[9]Neoh CF, He H, Li J, et al. Rapid and sensitive liquid chromatography/mass spectrometry assay for caspofungin in human aqueous humor[J].Antimicrob Agents Chemother,2010,54 (10): 4467-4470.
[10]Kirchhoff F, Lorenzl S, Vogeser M.An on-line solid phase extraction procedure for the routine quantification of urinary methylmalonic acid by liquid chromatography-tandem mass spectrometry [J]. Clini Chem Lab Med, 2010 ,48(11):1647-1650
[11]Aguilar G, Ferriols R, Lozano A,et al.Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients[J]. Critical Care,2017, 21(1): 17.
[12]Perlin DS.Echinocandin Resistance, Susceptibility testing and prophylaxis: implications for patient management[J].Drugs, 2014, 74(14): 1573-1585.
[13]Andes D, Ambrose PG, Hammel JP,et al.Use of pharmacokinetic-pharmacodynamic analyses to optimize therapy with the systemic antifungal micafungin for invasive candidiasis or candidemia [J]. Antimicrob Agents Chemother, 2011, 55(5): 2113-2121.
[14]Wanrooy MJ, Santoe RN, Kc VDE,et al.Simultaneous quantification of anidulafungin and caspofungin in plasma by an accurate and simple liquid chromatography tandem mass-spectrometric method[J].Therapeutic Drug Monitoring, 2013, 35(6): 778-784.
[15]Fluconazole P,Decosterd LA,Rochat B,et al.M Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole,itraconazole,hydroxyitraconazole,posaconazole,voriconazole,voriconazole-N-oxide,anidulafungin,and caspofungin[J].Antimicrob Agents Chemother,2010,54(12):5303-5315. |